Charles Schwab’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.65M | Buy |
567,538
+143,763
| +34% | +$671K | ﹤0.01% | 2587 |
|
|
2025
Q1 | $2.33M | Buy |
423,775
+20,903
| +5% | +$115K | ﹤0.01% | 2560 |
|
|
2024
Q4 | $1.37M | Sell |
402,872
-489
| -0.1% | -$1.66K | ﹤0.01% | 2801 |
|
|
2024
Q3 | $1.15M | Sell |
403,361
-1,221
| -0.3% | -$3.48K | ﹤0.01% | 2878 |
|
|
2024
Q2 | $910K | Buy |
404,582
+38,289
| +10% | +$86.2K | ﹤0.01% | 2973 |
|
|
2024
Q1 | $810K | Buy |
366,293
+1,911
| +0.5% | +$4.22K | ﹤0.01% | 2856 |
|
|
2023
Q4 | $856K | Sell |
364,382
-631
| -0.2% | -$1.48K | ﹤0.01% | 2886 |
|
|
2023
Q3 | $679K | Hold |
365,013
| – | – | ﹤0.01% | 2931 |
|
|
2023
Q2 | $956K | Sell |
365,013
-9,978
| -3% | -$26.1K | ﹤0.01% | 2788 |
|
|
2023
Q1 | $611K | Buy |
374,991
+26,754
| +8% | +$43.6K | ﹤0.01% | 2884 |
|
|
2022
Q4 | $463K | Buy |
348,237
+10,410
| +3% | +$13.8K | ﹤0.01% | 3023 |
|
|
2022
Q3 | $528K | Sell |
337,827
-563
| -0.2% | -$880 | ﹤0.01% | 2987 |
|
|
2022
Q2 | $522K | Buy |
338,390
+290,923
| +613% | +$449K | ﹤0.01% | 3060 |
|
|
2022
Q1 | $122K | Sell |
47,467
-19,543
| -29% | -$50.2K | ﹤0.01% | 3388 |
|
|
2021
Q4 | $197K | Buy |
67,010
+44,532
| +198% | +$131K | ﹤0.01% | 3363 |
|
|
2021
Q3 | $56K | Hold |
22,478
| – | – | ﹤0.01% | 3439 |
|
|
2021
Q2 | $92K | Sell |
22,478
-99,459
| -82% | -$407K | ﹤0.01% | 3300 |
|
|
2021
Q1 | $550K | Buy |
121,937
+4,064
| +3% | +$18.3K | ﹤0.01% | 3042 |
|
|
2020
Q4 | $580K | Buy |
117,873
+10,377
| +10% | +$51.1K | ﹤0.01% | 2937 |
|
|
2020
Q3 | $638K | Buy |
107,496
+14,950
| +16% | +$88.7K | ﹤0.01% | 2812 |
|
|
2020
Q2 | $247K | Buy |
92,546
+4,432
| +5% | +$11.8K | ﹤0.01% | 3127 |
|
|
2020
Q1 | $172K | Buy |
88,114
+20,531
| +30% | +$40.1K | ﹤0.01% | 3036 |
|
|
2019
Q4 | $477K | Hold |
67,583
| – | – | ﹤0.01% | 2829 |
|
|
2019
Q3 | $665K | Hold |
67,583
| – | – | ﹤0.01% | 2694 |
|
|
2019
Q2 | $774K | Buy |
67,583
+13,956
| +26% | +$160K | ﹤0.01% | 2659 |
|
|
2019
Q1 | $539K | Buy |
53,627
+39,136
| +270% | +$393K | ﹤0.01% | 2737 |
|
|
2018
Q4 | $247K | Hold |
14,491
| – | – | ﹤0.01% | 2986 |
|
|
2018
Q3 | $255K | Buy |
+14,491
| New | +$255K | ﹤0.01% | 3042 |
|